tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BriaCell Joins MSK’s 2025 Therapeutics Accelerator Program
Company AnnouncementsBriaCell Joins MSK’s 2025 Therapeutics Accelerator Program
6h ago
BCTX
BriaCell selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+
PremiumThe Fly
BriaCell selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+
7h ago
BCTX
BriaCell Announces Share Consolidation to Maintain Nasdaq Compliance
PremiumCompany Announcements
BriaCell Announces Share Consolidation to Maintain Nasdaq Compliance
8d ago
BCTX
BriaCell Expands Phase 3 Breast Cancer Study with UCLA Health Partnership
PremiumCompany Announcements
BriaCell Expands Phase 3 Breast Cancer Study with UCLA Health Partnership
13d ago
BCTX
BriaCell adds UCLA Health as site in Phase 3 breast cancer study
PremiumThe Fly
BriaCell adds UCLA Health as site in Phase 3 breast cancer study
13d ago
BCTX
BriaCell Secures New Zealand Patent for Cancer Immunotherapy
PremiumCompany AnnouncementsBriaCell Secures New Zealand Patent for Cancer Immunotherapy
14d ago
BCTX
BriaCell awarded New Zealand patent for its whole cell technology
Premium
The Fly
BriaCell awarded New Zealand patent for its whole cell technology
14d ago
BCTX
BriaCell’s BriaPro Files Patent for Innovative Cancer Treatment Platform
Premium
Company Announcements
BriaCell’s BriaPro Files Patent for Innovative Cancer Treatment Platform
15d ago
BCTX
BriaCell subsidiary BriaPro files patent application for TILsRx
PremiumThe Fly
BriaCell subsidiary BriaPro files patent application for TILsRx
15d ago
BCTX
BriaCell to Present Key Clinical Data at ESMO 2025
PremiumCompany Announcements
BriaCell to Present Key Clinical Data at ESMO 2025
19d ago
BCTX
Three new option listings and ten option delistings on July 21st
PremiumThe Fly
Three new option listings and ten option delistings on July 21st
23d ago
YI
HES
BriaCell Therapeutics Secures $15 Million in Public Offering
PremiumCompany Announcements
BriaCell Therapeutics Secures $15 Million in Public Offering
28d ago
BCTX
BriaCell sinks 61% to 79c after pricing 12M unit offering at $1.25
PremiumThe FlyBriaCell sinks 61% to 79c after pricing 12M unit offering at $1.25
29d ago
BCTX
BriaCell says $15M unit offering prices at $1.25 per unit
Premium
The Fly
BriaCell says $15M unit offering prices at $1.25 per unit
29d ago
BCTX
BriaCell adds Mayo Clinic to Phase 3 study in metastatic breast cancer
Premium
The Fly
BriaCell adds Mayo Clinic to Phase 3 study in metastatic breast cancer
29d ago
BCTX
BriaCell’s Bria-IMT Shows Promising Survival Advantage in Metastatic Breast Cancer
PremiumCompany Announcements
BriaCell’s Bria-IMT Shows Promising Survival Advantage in Metastatic Breast Cancer
1M ago
BCTX
BriaCell announces updated Phase 2 survival data fro Bria-IMT
PremiumThe Fly
BriaCell announces updated Phase 2 survival data fro Bria-IMT
1M ago
BCTX
Promising Clinical Developments and Positive Outlook Justify Buy Rating for BriaCell Therapeutics
PremiumRatings
Promising Clinical Developments and Positive Outlook Justify Buy Rating for BriaCell Therapeutics
1M ago
BCTX
BriaCell’s Bria-IMT Shows Promising Results in Advanced Breast Cancer Treatment
PremiumCompany Announcements
BriaCell’s Bria-IMT Shows Promising Results in Advanced Breast Cancer Treatment
1M ago
BCTX
BriaCell reports complete, sustained resolution of brain metastasis in patient
PremiumThe FlyBriaCell reports complete, sustained resolution of brain metastasis in patient
1M ago
BCTX
Morning Movers: Starbucks climbs following reports of interest in China business
Premium
The Fly
Morning Movers: Starbucks climbs following reports of interest in China business
1M ago
MRK
BCTX
BriaCell Achieves Milestone in Metastatic Breast Cancer Study with Bria-OTS
Premium
Company Announcements
BriaCell Achieves Milestone in Metastatic Breast Cancer Study with Bria-OTS
1M ago
BCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >